Clinical Trials
17 trialsNCT07284849 2026-05-26
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
Incyte Corporation
Phase 3 Recruiting
NCT07265674 2026-05-14
Beacon-BTC
J-Pharma Co., Ltd.
Phase 3 Recruiting
NCT06346197 2026-04-21
CIME
Centre Leon Berard
Phase 3 Recruiting
NCT04215731 2026-03-03
FOBEAR
Sun Yat-sen University
Phase 3 Recruiting
NCT07389265 2026-02-05
CAPRI-3 GOIM
University of Campania Luigi Vanvitelli
Phase 3 Recruiting
NCT05855200 2026-01-23
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
GlaxoSmithKline
Phase 3 Recruiting
NCT07309289 2025-12-30
NALIRIFOX Plus Targeted Therapy Versus FOLFOX Plus Targeted Therapy as First-line Treatment for Metastatic Colorectal Cancer
Shanghai Zhongshan Hospital
Phase 3 Recruiting
NCT06293625 2025-03-30
FOxTROT2France
Centre Hospitalier Universitaire Dijon
Phase 3 Recruiting
NCT05303714 2025-02-21
PIPAC_VEROne
Azienda Ospedaliera Universitaria Integrata Verona
Phase 3 Recruiting
NCT05534087 2024-11-29
CLAUDIA
Seoul National University Hospital
Phase 3 Recruiting
NCT04516681 2024-10-24
Combination of IV Ascorbic Acid and Adebrelimab in Metastatic Colorectal Cancer
Fudan University
Phase 3 Recruiting
NCT05815082 2023-04-18
ctDNA-guided Adjuvant Chemotherapy in Liver Metastasis of Colorectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 3 Recruiting
NCT05797077 2023-04-04
Postoperation Maintenance Therapy for Resectable Liver Metastases of Colorectal Cancer Guided by ctDNA
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 3 Recruiting
NCT05476432 2022-12-09
HAIC With One-day FOLFOX vs. HAIC With Two-day FOLFOX for Unresectable HCC: a Non-inferiority Study
Sun Yat-sen University
Phase 3 Recruiting
NCT04389086 2022-09-06
PelvEx II
Catharina Ziekenhuis Eindhoven
Phase 3 Recruiting
NCT05194878 2022-01-18
Neoadjuvant FOLFOXIRI Versus Immediate Surgery for Stage II and III Colon Cancers
Sun Yat-sen University
Phase 3 Recruiting
NCT03925662 2019-04-24
Mebendazole as Adjuvant Treatment for Colon Cancer
Tanta University
Phase 3 Recruiting